PeptideScanner

Cross-source evidence timeline

Semaglutide research timeline

Follow 237 selected, directly cited source records from April 4, 2017 through September 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

237Selected records
10Source years
4Evidence lanes
September 9, 2026Latest source date

Source year

2026

167 records
Literature metadata · 97Clinical trials · 54Regulatory · 14Safety · 2

  1. Clinical trials

    ClinicalTrials.gov record NCT03811561↗

    PeptideScanner retained ClinicalTrials.gov record NCT03811561 at 2026-09-09T19:17:17.089Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner September 9, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT07662213↗

    PeptideScanner retained ClinicalTrials.gov record NCT07662213 at 2026-09-09T19:17:17.121Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner September 9, 2026

  3. Literature metadata

    "I Believe in Santa Claus" and Ozempic: A Foucauldian Discourse Analysis of Holiday Health Advertising.↗

    PubMed lists PMID 40536021 in Qualitative health research as Journal Article, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 19, 2025 · day precisionAdded to PeptideScanner September 9, 2026

  4. Literature metadata

    Ozempic and thin line between therapy and dependence.↗

    PubMed lists PMID 42703141 in JPMA. The Journal of the Pakistan Medical Association as Journal Article, with publication-date metadata of 2026-08 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: August 2026 · month precisionAdded to PeptideScanner September 9, 2026

  5. Literature metadata

    Off-label semaglutide: A call for monitoring protocols in non-obese populations.↗

    PubMed lists PMID 42703150 in JPMA. The Journal of the Pakistan Medical Association as Journal Article, with publication-date metadata of 2026-08 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: August 2026 · month precisionAdded to PeptideScanner September 9, 2026

  6. Literature metadata

    Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.↗

    PubMed lists PMID 42602345 in Canadian journal of kidney health and disease as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: August 13, 2026 · day precisionAdded to PeptideScanner August 16, 2026

  7. Clinical trials

    ClinicalTrials.gov record NCT07087795↗

    PeptideScanner retained ClinicalTrials.gov record NCT07087795 at 2026-08-13T16:32:13.881Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 14, 2026

  8. Literature metadata

    Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis.↗

    PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: January 17, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  9. Literature metadata

    Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet.↗

    PubMed lists PMID 42076092 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: April 1, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  10. Literature metadata

    Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective.↗

    PubMed lists PMID 42076118 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: April 10, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  11. Literature metadata

    Semaglutide use for hypothalamic obesity and type 2 diabetes mellitus after suprasellar germinoma treatment.↗

    PubMed lists PMID 42158165 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: May 18, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  12. Literature metadata

    Optimization of nursing strategies for semaglutide treatment in overweight type 2 diabetes based on gene polymorphism.↗

    PubMed lists PMID 42232304 in Frontiers in clinical diabetes and healthcare as Journal Article, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: May 18, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  13. Literature metadata

    Topic and Sentiment Trends in Semaglutide Discussions on X: Subpopulation-Based Longitudinal Analysis.↗

    PubMed lists PMID 41734897 in Online journal of public health informatics as Journal Article, with publication-date metadata of 2026-02-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: February 24, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  14. Literature metadata

    Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial.↗

    PubMed lists PMID 41771053 in Diabetes care as Letter, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 1, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  15. Literature metadata

    Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China.↗

    PubMed lists PMID 41848818 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: March 18, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  16. Literature metadata

    Real-world use of oral semaglutide in adults with type 2 diabetes.↗

    PubMed lists PMID 42592768 in Danish medical journal as Journal Article, Multicenter Study, with publication-date metadata of 2026-06-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 16, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  17. Clinical trials

    ClinicalTrials.gov record NCT07218354↗

    PeptideScanner retained ClinicalTrials.gov record NCT07218354 at 2026-08-13T05:54:14.857Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  18. Clinical trials

    ClinicalTrials.gov record NCT03884075↗

    PeptideScanner retained ClinicalTrials.gov record NCT03884075 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 14, 2026

  19. Literature metadata

    PubMed record PMID 42264960↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42264960 at 2026-08-10T10:49:10.674Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  20. Literature metadata

    PubMed record PMID 42297751↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42297751 at 2026-08-10T10:49:10.683Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  21. Literature metadata

    PubMed record PMID 42297754↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42297754 at 2026-08-10T10:49:10.683Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  22. Literature metadata

    PubMed record PMID 42297758↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42297758 at 2026-08-10T10:49:10.684Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  23. Literature metadata

    PubMed record PMID 42365987↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42365987 at 2026-08-10T10:49:10.730Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  24. Literature metadata

    PubMed record PMID 42403263↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42403263 at 2026-08-10T10:49:10.745Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-06. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  25. Literature metadata

    PubMed record PMID 42420782↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42420782 at 2026-08-10T10:49:10.753Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  26. Literature metadata

    PubMed record PMID 42443711↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42443711 at 2026-08-10T10:49:10.765Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-13. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  27. Literature metadata

    PubMed record PMID 38151966↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 38151966 at 2026-08-10T10:49:06.863Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2023-12-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  28. Literature metadata

    PubMed record PMID 39776038↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 39776038 at 2026-08-10T10:49:06.923Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2025-01-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  29. Literature metadata

    PubMed record PMID 42569002↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42569002 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  30. Literature metadata

    PubMed record PMID 42569707↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42569707 at 2026-08-10T10:49:13.615Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  31. Literature metadata

    PubMed record PMID 42253285↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42253285 at 2026-08-10T10:49:10.672Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  32. Literature metadata

    PubMed record PMID 42567173↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42567173 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-08-07. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  33. Literature metadata

    PubMed record PMID 38082468↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 38082468 at 2026-08-10T10:49:06.856Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-12-12. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  34. Literature metadata

    PubMed record PMID 38195847↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 38195847 at 2026-08-10T10:49:06.868Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2024-01-10. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  35. Literature metadata

    PubMed record PMID 41766347↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41766347 at 2026-08-10T10:49:08.779Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-02. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  36. Literature metadata

    PubMed record PMID 42495930↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42495930 at 2026-08-10T10:49:10.785Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  37. Literature metadata

    PubMed record PMID 42541373↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42541373 at 2026-08-10T10:49:12.960Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  38. Literature metadata

    PubMed record PMID 42542232↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42542232 at 2026-08-10T10:49:12.963Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  39. Literature metadata

    PubMed record PMID 42560442↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42560442 at 2026-08-10T10:49:13.020Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 10, 2026

  40. Literature metadata

    PubMed record PMID 38016699↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 38016699 at 2026-08-10T10:49:06.852Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-11-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  41. Literature metadata

    PubMed record PMID 38073422↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 38073422 at 2026-08-10T10:49:06.856Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-12-11. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  42. Literature metadata

    PubMed record PMID 40015592↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 40015592 at 2026-08-10T10:49:06.932Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2025-02-27. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  43. Literature metadata

    PubMed record PMID 41532935↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41532935 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-01-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  44. Literature metadata

    PubMed record PMID 42504064↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42504064 at 2026-08-10T10:49:10.789Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  45. Literature metadata

    PubMed record PMID 42552573↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42552573 at 2026-08-10T10:49:12.986Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  46. Literature metadata

    PubMed record PMID 41944572↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41944572 at 2026-08-10T10:49:08.831Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-04-07. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  47. Literature metadata

    PubMed record PMID 42549476↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42549476 at 2026-08-10T10:49:12.984Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  48. Clinical trials

    ClinicalTrials.gov record NCT06015893↗

    PeptideScanner retained ClinicalTrials.gov record NCT06015893 at 2026-08-13T05:52:27.015Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  49. Literature metadata

    PubMed record PMID 42258199↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42258199 at 2026-08-10T10:49:10.672Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  50. Literature metadata

    PubMed record PMID 42288971↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42288971 at 2026-08-10T10:49:10.679Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  51. Literature metadata

    PubMed record PMID 42535667↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42535667 at 2026-08-10T10:49:12.941Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  52. Literature metadata

    PubMed record PMID 42546302↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42546302 at 2026-08-10T10:49:12.978Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  53. Literature metadata

    PubMed record PMID 42547311↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42547311 at 2026-08-10T10:49:12.979Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 11, 2026

  54. Literature metadata

    PubMed record PMID 42273973↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42273973 at 2026-08-10T10:49:10.675Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-06-11. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  55. Literature metadata

    PubMed record PMID 42437874↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42437874 at 2026-08-10T10:49:10.764Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-12. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  56. Literature metadata

    PubMed record PMID 42540132↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42540132 at 2026-08-10T10:49:12.959Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  57. Literature metadata

    PubMed record PMID 42210124↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42210124 at 2026-08-10T10:49:10.656Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  58. Literature metadata

    PubMed record PMID 41419187↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41419187 at 2026-08-10T10:49:08.723Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-19. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  59. Literature metadata

    PubMed record PMID 41475544↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41475544 at 2026-08-10T10:49:08.728Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  60. Literature metadata

    PubMed record PMID 41483046↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41483046 at 2026-08-10T10:49:08.730Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-01-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  61. Literature metadata

    PubMed record PMID 42513491↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42513491 at 2026-08-10T10:49:12.876Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  62. Regulatory

    Federal Register notice 2026-15285↗

    The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.↗

    Added to PeptideScanner August 21, 2026

  63. Literature metadata

    PubMed record PMID 41627802↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41627802 at 2026-08-10T18:13:40.591Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  64. Literature metadata

    PubMed record PMID 42219226↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42219226 at 2026-08-10T18:13:50.707Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-05-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  65. Literature metadata

    PubMed record PMID 42225300↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42225300 at 2026-08-10T18:13:50.717Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-06-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  66. Literature metadata

    PubMed record PMID 42361988↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42361988 at 2026-08-10T18:13:53.774Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  67. Literature metadata

    PubMed record PMID 42493207↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42493207 at 2026-08-10T18:13:56.730Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  68. Literature metadata

    PubMed record PMID 42518971↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42518971 at 2026-08-10T18:13:56.776Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  69. Literature metadata

    PubMed record PMID 42526426↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42526426 at 2026-08-10T18:13:57.051Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  70. Clinical trials

    ClinicalTrials.gov record NCT07732426↗

    PeptideScanner retained ClinicalTrials.gov record NCT07732426 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  71. Literature metadata

    PubMed record PMID 39655973↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 39655973 at 2026-08-10T18:13:36.057Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2024-12-10. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  72. Literature metadata

    PubMed record PMID 41778920↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41778920 at 2026-08-10T18:13:42.771Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-04. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  73. Literature metadata

    PubMed record PMID 42014432↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42014432 at 2026-08-10T18:13:48.770Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-04-21. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  74. Literature metadata

    PubMed record PMID 42516042↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42516042 at 2026-08-10T18:13:56.764Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  75. Literature metadata

    PubMed record PMID 42520650↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42520650 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  76. Clinical trials

    ClinicalTrials.gov record NCT06072963↗

    PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  77. Literature metadata

    PubMed record PMID 42314683↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42314683 at 2026-08-10T18:13:52.286Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-06-18. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  78. Literature metadata

    Titration and discontinuation of semaglutide for weight management in commercially insured US adults.↗

    PubMed lists PMID 40464214 in Obesity (Silver Spring, Md.) as Journal Article, with publication-date metadata of 2025-06-04 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 4, 2025 · day precisionAdded to PeptideScanner August 13, 2026

  79. Literature metadata

    Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations.↗

    PubMed lists PMID 40686549 in In silico pharmacology as Journal Article, with publication-date metadata of 2025-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 16, 2025 · day precisionAdded to PeptideScanner August 13, 2026

  80. Literature metadata

    The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.↗

    PubMed lists PMID 41729594 in The Journal of clinical endocrinology and metabolism as Journal Article, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 17, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  81. Literature metadata

    Ozempic and Wegovy Meet Congress: Political Economy Without Critique and Sociology Without Society.↗

    PubMed lists PMID 41744415 in International journal of social determinants of health and health services as Journal Article, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: February 26, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  82. Literature metadata

    Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.↗

    PubMed lists PMID 41780559 in European heart journal as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 1, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  83. Literature metadata

    Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.↗

    PubMed lists PMID 41994903 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: April 17, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  84. Literature metadata

    What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial.↗

    PubMed lists PMID 42308137 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, with publication-date metadata of 2026-06-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 18, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  85. Literature metadata

    PubMed record PMID 42503575↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 42503575 at 2026-08-10T18:13:56.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-26. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.↗

    Added to PeptideScanner August 12, 2026

  86. Literature metadata

    The silent rise of self-prescribed semaglutide use among non-obese young adults in the Middle East.↗

    PubMed lists PMID 42487380 in Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit as Letter, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 28, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  87. Clinical trials

    ClinicalTrials.gov record NCT06299098↗

    PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  88. Clinical trials

    ClinicalTrials.gov record NCT06967389↗

    PeptideScanner retained ClinicalTrials.gov record NCT06967389 at 2026-08-10T18:10:03.916Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  89. Clinical trials

    ClinicalTrials.gov record NCT06975111↗

    PeptideScanner retained ClinicalTrials.gov record NCT06975111 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  90. Literature metadata

    Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations.↗

    PubMed lists PMID 42474946 in Indian pediatrics as Letter, with publication-date metadata of 2026-07-20 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 20, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  91. Literature metadata

    Readability and understandability of online patient education on semaglutide.↗

    PubMed lists PMID 41877445 in Health informatics journal as Journal Article, with publication-date metadata of 2026-03-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: March 24, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  92. Literature metadata

    Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system.↗

    PubMed lists PMID 42166306 in Journal of managed care & specialty pharmacy as Journal Article, Observational Study, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 2026 · month precisionAdded to PeptideScanner August 13, 2026

  93. Literature metadata

    Influence of Social Media on Self-Medication Behavior: A Study on Ozempic Use Among Emirati University Students.↗

    PubMed lists PMID 42196730 in International journal of environmental research and public health as Journal Article, with publication-date metadata of 2026-05-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: May 12, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  94. Literature metadata

    Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use.↗

    PubMed lists PMID 42469146 in Nutrition, metabolism, and cardiovascular diseases : NMCD as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 16, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  95. Clinical trials

    ClinicalTrials.gov record NCT06814938↗

    PeptideScanner retained ClinicalTrials.gov record NCT06814938 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  96. Literature metadata

    Redefining peptide therapeutics with semaglutide.↗

    PubMed lists PMID 38321235 in Nature chemistry as Journal Article, with publication-date metadata of 2024-02 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: February 2024 · month precisionAdded to PeptideScanner August 13, 2026

  97. Literature metadata

    The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.↗

    PubMed lists PMID 42462869 in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery as Editorial, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 16, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  98. Literature metadata

    Semaglutide treatment for children with obesity: an observational study.↗

    PubMed lists PMID 38471743 in Archives of disease in childhood as Journal Article, Observational Study, with publication-date metadata of 2024-09-25 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: September 25, 2024 · day precisionAdded to PeptideScanner August 13, 2026

  99. Literature metadata

    A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026.↗

    PubMed lists PMID 42313535 in JAMA as Journal Article, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 14, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  100. Literature metadata

    Semaglutide in patients with hidradenitis suppurativa and obesity.↗

    PubMed lists PMID 41832804 in Medicina clinica as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: March 12, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  101. Literature metadata

    Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.↗

    PubMed lists PMID 42436546 in Molecular brain as Journal Article, with publication-date metadata of 2026-07-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 11, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  102. Literature metadata

    Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.↗

    PubMed lists PMID 41772149 in Nature medicine as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase II, with publication-date metadata of 2026-03-02 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: March 2, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  103. Literature metadata

    Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.↗

    PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 10, 2026 · day precisionAdded to PeptideScanner August 13, 2026

  104. Clinical trials

    ClinicalTrials.gov record NCT05616013↗

    PeptideScanner retained ClinicalTrials.gov record NCT05616013 at 2026-08-10T18:10:03.915Z. Its registry update date was 2026-07-08, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  105. Clinical trials

    ClinicalTrials.gov record NCT05569772↗

    PeptideScanner retained ClinicalTrials.gov record NCT05569772 at 2026-08-10T18:10:03.935Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  106. Clinical trials

    ClinicalTrials.gov record NCT05371496↗

    PeptideScanner retained ClinicalTrials.gov record NCT05371496 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  107. Literature metadata

    Semaglutide in Schizophrenia-A Top Clinical Trial.↗

    PubMed lists PMID 42384388 in JAMA psychiatry as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: July 1, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  108. Regulatory

    Semaglutide DailyMed SPL version 19↗

    DailyMed lists Structured Product Labeling version 19 for the reviewed Semaglutide label family with a published date of 2026-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  109. Literature metadata

    Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.↗

    PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: October 11, 2025 · day precisionAdded to PeptideScanner August 14, 2026

  110. Literature metadata

    Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.↗

    PubMed lists PMID 42086873 in Pharmaceutical research as Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: May 5, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  111. Clinical trials

    ClinicalTrials.gov record NCT04822181↗

    PeptideScanner retained ClinicalTrials.gov record NCT04822181 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner July 31, 2026

  112. Literature metadata

    Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis.↗

    PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: May 30, 2026 · day precisionAdded to PeptideScanner August 14, 2026

  113. Literature metadata

    Secondary alopecia due to semaglutide.↗

    PubMed lists PMID 42364353 in Medicina clinica as Letter, with publication-date metadata of 2026-06-27 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: June 27, 2026 · day precisionAdded to PeptideScanner August 16, 2026

  114. Regulatory

    Federal Register notice 2026-12937↗

    The Federal Register published notice 2026-12937, attributed to FDA and its parent HHS department, on 2026-06-26. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide, Semaglutide and Tirzepatide.↗

    Added to PeptideScanner August 21, 2026

  115. Literature metadata

    Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic administration.↗

    PubMed lists PMID 40850442 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-22 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: August 22, 2025 · day precisionAdded to PeptideScanner August 16, 2026

  116. Literature metadata

    Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States.↗

    PubMed lists PMID 41524543 in Expert review of pharmacoeconomics & outcomes research as Journal Article, Observational Study, with publication-date metadata of 2026-01-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

    Attributed publication date: January 12, 2026 · day precisionAdded to PeptideScanner August 16, 2026

  117. Clinical trials

    ClinicalTrials.gov record NCT04777409↗

    PeptideScanner retained ClinicalTrials.gov record NCT04777409 at 2026-07-30T16:19:03.047Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 8, 2026

  118. Clinical trials

    ClinicalTrials.gov record NCT07592546↗

    PeptideScanner retained ClinicalTrials.gov record NCT07592546 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 8, 2026

  119. Clinical trials

    ClinicalTrials.gov record NCT07505303↗

    PeptideScanner retained ClinicalTrials.gov record NCT07505303 at 2026-07-30T16:19:03.067Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  120. Clinical trials

    ClinicalTrials.gov record NCT07668414↗

    PeptideScanner retained ClinicalTrials.gov record NCT07668414 at 2026-07-30T16:19:03.061Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  121. Clinical trials

    ClinicalTrials.gov record NCT05726227↗

    PeptideScanner retained ClinicalTrials.gov record NCT05726227 at 2026-07-30T16:19:03.202Z. Its registry update date was 2026-06-16, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  122. Clinical trials

    ClinicalTrials.gov record NCT07282769↗

    PeptideScanner retained ClinicalTrials.gov record NCT07282769 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  123. Clinical trials

    ClinicalTrials.gov record NCT07462663↗

    PeptideScanner retained ClinicalTrials.gov record NCT07462663 at 2026-07-30T16:19:03.043Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  124. Clinical trials

    ClinicalTrials.gov record NCT05424003↗

    PeptideScanner retained ClinicalTrials.gov record NCT05424003 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  125. Clinical trials

    ClinicalTrials.gov record NCT07627074↗

    PeptideScanner retained ClinicalTrials.gov record NCT07627074 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  126. Clinical trials

    ClinicalTrials.gov record NCT07204249↗

    PeptideScanner retained ClinicalTrials.gov record NCT07204249 at 2026-07-30T16:19:03.057Z. Its registry update date was 2026-06-03, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  127. Clinical trials

    ClinicalTrials.gov record NCT06571383↗

    PeptideScanner retained ClinicalTrials.gov record NCT06571383 at 2026-07-30T16:19:03.050Z. Its registry update date was 2026-06-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  128. Safety

    FDA details concerns with unapproved GLP-1 products↗

    FDA's public page describes agency concerns and actions involving unapproved versions of semaglutide and tirzepatide, with adverse-event information dated May 31, 2026.↗

    Added to PeptideScanner July 29, 2026

  129. Clinical trials

    ClinicalTrials.gov record NCT07610174↗

    PeptideScanner retained ClinicalTrials.gov record NCT07610174 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  130. Clinical trials

    ClinicalTrials.gov record NCT05333003↗

    PeptideScanner retained ClinicalTrials.gov record NCT05333003 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  131. Regulatory

    Semaglutide DailyMed SPL version 18↗

    DailyMed lists Structured Product Labeling version 18 for the reviewed Semaglutide label family with a published date of 2026-05-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  132. Clinical trials

    ClinicalTrials.gov record NCT04469855↗

    PeptideScanner retained ClinicalTrials.gov record NCT04469855 at 2026-07-30T16:19:36.922Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  133. Clinical trials

    ClinicalTrials.gov record NCT06041217↗

    PeptideScanner retained ClinicalTrials.gov record NCT06041217 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-18, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  134. Clinical trials

    ClinicalTrials.gov record NCT07523633↗

    PeptideScanner retained ClinicalTrials.gov record NCT07523633 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  135. Clinical trials

    ClinicalTrials.gov record NCT05586802↗

    PeptideScanner retained ClinicalTrials.gov record NCT05586802 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  136. Clinical trials

    ClinicalTrials.gov record NCT07059377↗

    PeptideScanner retained ClinicalTrials.gov record NCT07059377 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  137. Clinical trials

    ClinicalTrials.gov record NCT04019197↗

    PeptideScanner retained ClinicalTrials.gov record NCT04019197 at 2026-07-30T16:19:36.918Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  138. Regulatory

    Federal Register notice 2026-08552↗

    The Federal Register published notice 2026-08552, attributed to FDA and its parent HHS department, on 2026-05-01. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide and Tirzepatide.↗

    Added to PeptideScanner August 21, 2026

  139. Regulatory

    Federal Register notice 2026-08435↗

    The Federal Register published notice 2026-08435, attributed to FDA and its parent HHS department, on 2026-04-30. Its official title is “Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  140. Regulatory

    FDA proposes excluding three GLP-1 ingredients from the 503B bulks list↗

    FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list of bulk substances that 503B outsourcing facilities may use for compounding.↗

    Added to PeptideScanner July 29, 2026

  141. Clinical trials

    ClinicalTrials.gov record NCT04174755↗

    PeptideScanner retained ClinicalTrials.gov record NCT04174755 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  142. Clinical trials

    ClinicalTrials.gov record NCT05646706↗

    PeptideScanner retained ClinicalTrials.gov record NCT05646706 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-23, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  143. Clinical trials

    ClinicalTrials.gov record NCT06283667↗

    PeptideScanner retained ClinicalTrials.gov record NCT06283667 at 2026-07-30T16:20:49.310Z. Its registry update date was 2026-04-22, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  144. Clinical trials

    ClinicalTrials.gov record NCT05746039↗

    PeptideScanner retained ClinicalTrials.gov record NCT05746039 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  145. Clinical trials

    ClinicalTrials.gov record NCT06604624↗

    PeptideScanner retained ClinicalTrials.gov record NCT06604624 at 2026-07-30T16:20:49.309Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  146. Regulatory

    Semaglutide DailyMed SPL version 17↗

    DailyMed lists Structured Product Labeling version 17 for the reviewed Semaglutide label family with a published date of 2026-04-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  147. Clinical trials

    ClinicalTrials.gov record NCT06118203↗

    PeptideScanner retained ClinicalTrials.gov record NCT06118203 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  148. Clinical trials

    ClinicalTrials.gov record NCT07227948↗

    PeptideScanner retained ClinicalTrials.gov record NCT07227948 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  149. Regulatory

    FDA announces approval of a higher-dose semaglutide product↗

    FDA announced approval of a higher-dose Wegovy product, adding a regulatory event to the semaglutide profile's selected official records.↗

    Added to PeptideScanner July 29, 2026

  150. Clinical trials

    ClinicalTrials.gov record NCT06934655↗

    PeptideScanner retained ClinicalTrials.gov record NCT06934655 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  151. Clinical trials

    ClinicalTrials.gov record NCT06989177↗

    PeptideScanner retained ClinicalTrials.gov record NCT06989177 at 2026-07-30T16:22:22.331Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  152. Clinical trials

    ClinicalTrials.gov record NCT06989203↗

    PeptideScanner retained ClinicalTrials.gov record NCT06989203 at 2026-07-30T16:22:22.329Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  153. Clinical trials

    ClinicalTrials.gov record NCT07213466↗

    PeptideScanner retained ClinicalTrials.gov record NCT07213466 at 2026-07-30T16:22:22.332Z. Its registry update date was 2026-03-11, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  154. Regulatory

    Semaglutide DailyMed SPL version 16↗

    DailyMed lists Structured Product Labeling version 16 for the reviewed Semaglutide label family with a published date of 2026-03-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  155. Regulatory

    Federal Register notice 2026-03963↗

    The Federal Register published notice 2026-03963, attributed to FDA and its parent HHS department, on 2026-02-27. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide and Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  156. Clinical trials

    ClinicalTrials.gov record NCT06027567↗

    PeptideScanner retained ClinicalTrials.gov record NCT06027567 at 2026-07-30T16:23:45.644Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  157. Clinical trials

    ClinicalTrials.gov record NCT05891496↗

    PeptideScanner retained ClinicalTrials.gov record NCT05891496 at 2026-07-30T16:23:45.669Z. Its registry update date was 2026-02-24, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  158. Regulatory

    Semaglutide DailyMed SPL version 15↗

    DailyMed lists Structured Product Labeling version 15 for the reviewed Semaglutide label family with a published date of 2026-02-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  159. Regulatory

    Federal Register notice 2026-02786↗

    The Federal Register published notice 2026-02786, attributed to FDA and its parent HHS department, on 2026-02-12. Its official title is “Jeremy Spencer Brown: Final Debarment Order,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  160. Clinical trials

    ClinicalTrials.gov record NCT06914102↗

    PeptideScanner retained ClinicalTrials.gov record NCT06914102 at 2026-07-30T16:25:18.004Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  161. Clinical trials

    ClinicalTrials.gov record NCT04251156↗

    PeptideScanner retained ClinicalTrials.gov record NCT04251156 at 2026-07-30T16:25:18.009Z. Its registry update date was 2026-01-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  162. Clinical trials

    ClinicalTrials.gov record NCT05788965↗

    PeptideScanner retained ClinicalTrials.gov record NCT05788965 at 2026-07-30T16:25:18.013Z. Its registry update date was 2026-01-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  163. Clinical trials

    ClinicalTrials.gov record NCT07242534↗

    PeptideScanner retained ClinicalTrials.gov record NCT07242534 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  164. Clinical trials

    ClinicalTrials.gov record NCT06852391↗

    PeptideScanner retained ClinicalTrials.gov record NCT06852391 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-14, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  165. Clinical trials

    ClinicalTrials.gov record NCT06042153↗

    PeptideScanner retained ClinicalTrials.gov record NCT06042153 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-13, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  166. Safety

    FDA requests removal of a warning from certain GLP-1 drug labels↗

    FDA asked manufacturers to remove suicidal behavior and ideation warning language from certain semaglutide, tirzepatide, and liraglutide labels.↗

    Added to PeptideScanner July 29, 2026

  167. Regulatory

    Semaglutide DailyMed SPL version 14↗

    DailyMed lists Structured Product Labeling version 14 for the reviewed Semaglutide label family with a published date of 2026-01-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

Source year

2025

32 records
Clinical trials · 26Regulatory · 6

  1. Clinical trials

    ClinicalTrials.gov record NCT05702931↗

    PeptideScanner retained ClinicalTrials.gov record NCT05702931 at 2026-07-30T18:18:33.515Z. Its registry update date was 2025-12-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  2. Regulatory

    Drugs@FDA application NDA218316↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 218316 with status AP dated 2025-12-22, and names semaglutide among the application record's active ingredients.↗

    Added to PeptideScanner August 14, 2026

  3. Clinical trials

    ClinicalTrials.gov record NCT05891587↗

    PeptideScanner retained ClinicalTrials.gov record NCT05891587 at 2026-07-30T18:18:33.508Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  4. Clinical trials

    ClinicalTrials.gov record NCT07280221↗

    PeptideScanner retained ClinicalTrials.gov record NCT07280221 at 2026-07-30T18:18:33.524Z. Its registry update date was 2025-12-12, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  5. Clinical trials

    ClinicalTrials.gov record NCT04102189↗

    PeptideScanner retained ClinicalTrials.gov record NCT04102189 at 2026-07-30T18:18:33.504Z. Its registry update date was 2025-12-11, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  6. Regulatory

    Semaglutide DailyMed SPL version 13↗

    DailyMed lists Structured Product Labeling version 13 for the reviewed Semaglutide label family with a published date of 2025-12-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  7. Regulatory

    Federal Register notice 2025-22131↗

    The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.↗

    Added to PeptideScanner August 21, 2026

  8. Clinical trials

    ClinicalTrials.gov record NCT04788511↗

    PeptideScanner retained ClinicalTrials.gov record NCT04788511 at 2026-07-30T18:18:33.488Z. Its registry update date was 2025-12-05, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  9. Clinical trials

    ClinicalTrials.gov record NCT07239570↗

    PeptideScanner retained ClinicalTrials.gov record NCT07239570 at 2026-07-30T18:19:48.218Z. Its registry update date was 2025-11-20, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  10. Regulatory

    Semaglutide DailyMed SPL version 12↗

    DailyMed lists Structured Product Labeling version 12 for the reviewed Semaglutide label family with a published date of 2025-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  11. Clinical trials

    ClinicalTrials.gov record NCT06499857↗

    PeptideScanner retained ClinicalTrials.gov record NCT06499857 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-14, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  12. Clinical trials

    ClinicalTrials.gov record NCT06446531↗

    PeptideScanner retained ClinicalTrials.gov record NCT06446531 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  13. Regulatory

    Federal Register notice 2025-19345↗

    The Federal Register published notice 2025-19345, attributed to FDA and its parent HHS department, on 2025-10-02. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  14. Clinical trials

    ClinicalTrials.gov record NCT04466345↗

    PeptideScanner retained ClinicalTrials.gov record NCT04466345 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  15. Clinical trials

    ClinicalTrials.gov record NCT06639464↗

    PeptideScanner retained ClinicalTrials.gov record NCT06639464 at 2026-07-30T18:22:04.916Z. Its registry update date was 2025-09-26, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  16. Clinical trials

    ClinicalTrials.gov record NCT05548647↗

    PeptideScanner retained ClinicalTrials.gov record NCT05548647 at 2026-07-30T18:22:04.915Z. Its registry update date was 2025-09-08, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  17. Regulatory

    Semaglutide DailyMed SPL version 11↗

    DailyMed lists Structured Product Labeling version 11 for the reviewed Semaglutide label family with a published date of 2025-08-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  18. Clinical trials

    ClinicalTrials.gov record NCT06986993↗

    PeptideScanner retained ClinicalTrials.gov record NCT06986993 at 2026-07-30T18:23:09.822Z. Its registry update date was 2025-08-27, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  19. Clinical trials

    ClinicalTrials.gov record NCT06691243↗

    PeptideScanner retained ClinicalTrials.gov record NCT06691243 at 2026-07-30T18:23:09.829Z. Its registry update date was 2025-08-24, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  20. Clinical trials

    ClinicalTrials.gov record NCT05530577↗

    PeptideScanner retained ClinicalTrials.gov record NCT05530577 at 2026-07-30T18:23:09.828Z. Its registry update date was 2025-08-22, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  21. Clinical trials

    ClinicalTrials.gov record NCT05895643↗

    PeptideScanner retained ClinicalTrials.gov record NCT05895643 at 2026-07-30T18:23:09.822Z. Its registry update date was 2025-08-05, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  22. Clinical trials

    ClinicalTrials.gov record NCT07090343↗

    PeptideScanner retained ClinicalTrials.gov record NCT07090343 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  23. Clinical trials

    ClinicalTrials.gov record NCT04451837↗

    PeptideScanner retained ClinicalTrials.gov record NCT04451837 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-16, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  24. Clinical trials

    ClinicalTrials.gov record NCT07043361↗

    PeptideScanner retained ClinicalTrials.gov record NCT07043361 at 2026-07-30T18:24:37.183Z. Its registry update date was 2025-07-09, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  25. Clinical trials

    ClinicalTrials.gov record NCT07018544↗

    PeptideScanner retained ClinicalTrials.gov record NCT07018544 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  26. Clinical trials

    ClinicalTrials.gov record NCT06937060↗

    PeptideScanner retained ClinicalTrials.gov record NCT06937060 at 2026-07-30T18:27:14.162Z. Its registry update date was 2025-05-13, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  27. Clinical trials

    ClinicalTrials.gov record NCT06959784↗

    PeptideScanner retained ClinicalTrials.gov record NCT06959784 at 2026-07-30T18:27:14.158Z. Its registry update date was 2025-05-07, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  28. Clinical trials

    ClinicalTrials.gov record NCT04889183↗

    PeptideScanner retained ClinicalTrials.gov record NCT04889183 at 2026-07-30T18:29:04.229Z. Its registry update date was 2025-04-22, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  29. Clinical trials

    ClinicalTrials.gov record NCT05302596↗

    PeptideScanner retained ClinicalTrials.gov record NCT05302596 at 2026-07-30T18:29:04.234Z. Its registry update date was 2025-04-17, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  30. Clinical trials

    ClinicalTrials.gov record NCT05520775↗

    PeptideScanner retained ClinicalTrials.gov record NCT05520775 at 2026-07-30T18:29:04.228Z. Its registry update date was 2025-04-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  31. Clinical trials

    ClinicalTrials.gov record NCT04873050↗

    PeptideScanner retained ClinicalTrials.gov record NCT04873050 at 2026-07-30T18:30:10.991Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  32. Clinical trials

    ClinicalTrials.gov record NCT06764056↗

    PeptideScanner retained ClinicalTrials.gov record NCT06764056 at 2026-07-30T18:32:24.991Z. Its registry update date was 2025-01-08, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

Source year

2024

11 records
Clinical trials · 7Regulatory · 4

  1. Regulatory

    Semaglutide DailyMed SPL version 10↗

    DailyMed lists Structured Product Labeling version 10 for the reviewed Semaglutide label family with a published date of 2024-12-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT06234111↗

    PeptideScanner retained ClinicalTrials.gov record NCT06234111 at 2026-07-30T18:37:14.697Z. Its registry update date was 2024-12-12, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  3. Clinical trials

    ClinicalTrials.gov record NCT06629688↗

    PeptideScanner retained ClinicalTrials.gov record NCT06629688 at 2026-07-30T18:37:14.696Z. Its registry update date was 2024-12-05, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  4. Regulatory

    Semaglutide DailyMed SPL version 9↗

    DailyMed lists Structured Product Labeling version 9 for the reviewed Semaglutide label family with a published date of 2024-11-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  5. Clinical trials

    ClinicalTrials.gov record NCT04216589↗

    PeptideScanner retained ClinicalTrials.gov record NCT04216589 at 2026-07-30T18:39:33.783Z. Its registry update date was 2024-10-01, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  6. Clinical trials

    ClinicalTrials.gov record NCT03574597↗

    PeptideScanner retained ClinicalTrials.gov record NCT03574597 at 2026-07-30T18:41:37.951Z. Its registry update date was 2024-08-30, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  7. Clinical trials

    ClinicalTrials.gov record NCT06541509↗

    PeptideScanner retained ClinicalTrials.gov record NCT06541509 at 2026-07-30T18:41:37.930Z. Its registry update date was 2024-08-07, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  8. Clinical trials

    ClinicalTrials.gov record NCT03987451↗

    PeptideScanner retained ClinicalTrials.gov record NCT03987451 at 2026-07-30T18:45:10.889Z. Its registry update date was 2024-05-29, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  9. Regulatory

    Semaglutide DailyMed SPL version 8↗

    DailyMed lists Structured Product Labeling version 8 for the reviewed Semaglutide label family with a published date of 2024-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  10. Clinical trials

    ClinicalTrials.gov record NCT05813249↗

    PeptideScanner retained ClinicalTrials.gov record NCT05813249 at 2026-07-30T18:46:20.405Z. Its registry update date was 2024-04-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 9, 2026

  11. Regulatory

    Semaglutide DailyMed SPL version 7↗

    DailyMed lists Structured Product Labeling version 7 for the reviewed Semaglutide label family with a published date of 2024-03-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

Source year

2023

6 records
Regulatory · 5Clinical trials · 1

  1. Regulatory

    Federal Register notice 2023-25485↗

    The Federal Register published notice 2023-25485, attributed to FDA and its parent HHS department, on 2023-11-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT04263415↗

    PeptideScanner retained ClinicalTrials.gov record NCT04263415 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-08, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  3. Regulatory

    Semaglutide DailyMed SPL version 6↗

    DailyMed lists Structured Product Labeling version 6 for the reviewed Semaglutide label family with a published date of 2023-08-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  4. Regulatory

    Semaglutide DailyMed SPL version 5↗

    DailyMed lists Structured Product Labeling version 5 for the reviewed Semaglutide label family with a published date of 2023-03-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  5. Regulatory

    Semaglutide DailyMed SPL version 4↗

    DailyMed lists Structured Product Labeling version 4 for the reviewed Semaglutide label family with a published date of 2023-02-27. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  6. Regulatory

    Semaglutide DailyMed SPL version 3↗

    DailyMed lists Structured Product Labeling version 3 for the reviewed Semaglutide label family with a published date of 2023-01-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

Source year

2022

2 records
Clinical trials · 1Regulatory · 1

  1. Regulatory

    Semaglutide DailyMed SPL version 2↗

    DailyMed lists Structured Product Labeling version 2 for the reviewed Semaglutide label family with a published date of 2022-11-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT03548987↗

    PeptideScanner retained ClinicalTrials.gov record NCT03548987 at 2026-07-30T19:44:52.954Z. Its registry update date was 2022-01-19, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

Source year

2021

6 records
Regulatory · 3Clinical trials · 2Safety · 1

  1. Clinical trials

    ClinicalTrials.gov record NCT03357380↗

    PeptideScanner retained ClinicalTrials.gov record NCT03357380 at 2026-07-30T19:56:31.568Z. Its registry update date was 2021-11-22, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT03611582↗

    PeptideScanner retained ClinicalTrials.gov record NCT03611582 at 2026-07-30T19:56:31.576Z. Its registry update date was 2021-11-11, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  3. Regulatory

    Federal Register notice 2021-18072↗

    The Federal Register published notice 2021-18072, attributed to FDA and its parent HHS department, on 2021-08-23. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  4. Regulatory

    Semaglutide DailyMed SPL version 1↗

    DailyMed lists Structured Product Labeling version 1 for the reviewed Semaglutide label family with a published date of 2021-06-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗

    Added to PeptideScanner August 22, 2026

  5. Regulatory

    Drugs@FDA application NDA215256↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 215256 with status AP dated 2021-06-04, and names semaglutide among the application record's active ingredients.↗

    Added to PeptideScanner August 14, 2026

  6. Safety

    FDA enforcement report D-0536-2021↗

    FDA's dated enforcement report D-0536-2021 lists Class II and source status Terminated for Cardinal Health Inc. PeptideScanner connects the report to reviewed application NDA213051 through exact openFDA application-number annotations.↗

    Added to PeptideScanner August 25, 2026

Source year

2020

4 records
Clinical trials · 2Regulatory · 2

  1. Clinical trials

    ClinicalTrials.gov record NCT03842202↗

    PeptideScanner retained ClinicalTrials.gov record NCT03842202 at 2026-07-30T20:18:37.981Z. Its registry update date was 2020-12-24, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  2. Regulatory

    Federal Register notice 2020-04320↗

    The Federal Register published notice 2020-04320, attributed to FDA and its parent HHS department, on 2020-03-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide and Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  3. Clinical trials

    ClinicalTrials.gov record NCT04175665↗

    PeptideScanner retained ClinicalTrials.gov record NCT04175665 at 2026-07-30T20:32:04.760Z. Its registry update date was 2020-02-21, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  4. Regulatory

    Drugs@FDA application NDA213182↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 213182 with status AP dated 2020-01-16, and names semaglutide among the application record's active ingredients.↗

    Added to PeptideScanner August 14, 2026

Source year

2019

3 records
Regulatory · 2Clinical trials · 1

  1. Regulatory

    Federal Register notice 2019-25850↗

    The Federal Register published notice 2019-25850, attributed to FDA and its parent HHS department, on 2019-11-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OZEMPIC,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  2. Regulatory

    Drugs@FDA application NDA213051↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 213051 with status AP dated 2019-09-20, and names semaglutide among the application record's active ingredients.↗

    Added to PeptideScanner August 14, 2026

  3. Clinical trials

    ClinicalTrials.gov record NCT03466567↗

    PeptideScanner retained ClinicalTrials.gov record NCT03466567 at 2026-07-30T20:50:35.918Z. Its registry update date was 2019-06-19, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

Source year

2018

2 records
Clinical trials · 2

  1. Clinical trials

    ClinicalTrials.gov record NCT02064348↗

    PeptideScanner retained ClinicalTrials.gov record NCT02064348 at 2026-07-30T21:11:31.040Z. Its registry update date was 2018-06-13, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT02146079↗

    PeptideScanner retained ClinicalTrials.gov record NCT02146079 at 2026-07-30T21:11:31.042Z. Its registry update date was 2018-04-18, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

Source year

2017

4 records
Clinical trials · 2Regulatory · 2

  1. Regulatory

    Drugs@FDA application NDA209637↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 209637 with status AP dated 2017-12-05, and names semaglutide among the application record's active ingredients.↗

    Added to PeptideScanner August 14, 2026

  2. Clinical trials

    ClinicalTrials.gov record NCT02079870↗

    PeptideScanner retained ClinicalTrials.gov record NCT02079870 at 2026-07-30T21:22:00.245Z. Its registry update date was 2017-12-02, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026

  3. Regulatory

    Federal Register notice 2017-21176↗

    The Federal Register published notice 2017-21176, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.↗

    Added to PeptideScanner August 21, 2026

  4. Clinical trials

    ClinicalTrials.gov record NCT02022254↗

    PeptideScanner retained ClinicalTrials.gov record NCT02022254 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-04-04, and PeptideScanner's reviewed identity mapping was semaglutide.↗

    Added to PeptideScanner August 13, 2026
Public beta · Selective source coverageNot medical advice · No dosing or purchasing guidance